VJHemOnc is committed to improving our service to you

ICML 2019 | Resisting CAR-T resistance in lymphoma: the strategies

VJHemOnc is committed to improving our service to you

Sattva Neelapu

Sattva Neelapu, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the strategies to overcome or avoid resistance to anti-CD19 CAR T-cell therapy in lymphoma. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter